首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1758篇
  免费   87篇
  国内免费   2篇
耳鼻咽喉   22篇
儿科学   37篇
妇产科学   39篇
基础医学   183篇
口腔科学   29篇
临床医学   273篇
内科学   377篇
皮肤病学   21篇
神经病学   138篇
特种医学   70篇
外科学   234篇
综合类   25篇
一般理论   1篇
预防医学   112篇
眼科学   5篇
药学   223篇
中国医学   2篇
肿瘤学   56篇
  2023年   23篇
  2022年   20篇
  2021年   64篇
  2020年   32篇
  2019年   73篇
  2018年   60篇
  2017年   33篇
  2016年   40篇
  2015年   51篇
  2014年   67篇
  2013年   82篇
  2012年   131篇
  2011年   123篇
  2010年   72篇
  2009年   62篇
  2008年   99篇
  2007年   89篇
  2006年   104篇
  2005年   115篇
  2004年   105篇
  2003年   107篇
  2002年   75篇
  2001年   30篇
  2000年   28篇
  1999年   29篇
  1998年   20篇
  1997年   8篇
  1996年   14篇
  1995年   5篇
  1994年   8篇
  1993年   2篇
  1992年   5篇
  1991年   7篇
  1990年   5篇
  1989年   4篇
  1988年   6篇
  1985年   2篇
  1983年   3篇
  1980年   2篇
  1979年   4篇
  1975年   3篇
  1974年   7篇
  1973年   3篇
  1972年   3篇
  1971年   4篇
  1970年   4篇
  1968年   2篇
  1967年   1篇
  1966年   3篇
  1929年   1篇
排序方式: 共有1847条查询结果,搜索用时 78 毫秒
1.
Introduction: The Hedgehog (HH) pathway constitutes a collection of signaling molecules which critically influence embryogenesis. In adults, however, the HH pathway remains integral to the proliferation, maintenance, and apoptosis of adult stem cells including hematopoietic stem cells.

Areas covered: We discuss the current understanding of the HH pathway as it relates to normal hematopoiesis, the pathology of acute myeloid leukemia (AML), the rationale for and data from combination therapies including HH pathway inhibitors, and ultimately the prospects that might offer promise in targeting this pathway in AML.

Expert opinion: Efforts to target the HH pathway have been focused on impeding this disposition and restoring chemosensitivity to conventional myeloid neoplasm therapies. The year 2018 saw the first approval of a HH pathway inhibitor (glasdegib) for AML, though for an older population and in combination with an uncommonly-used therapy. Several other clinical trials with agents targeting modulators of HH signaling in AML and MDS are underway. Further study and understanding of the interplay between the numerous aspects of HH signaling and how it relates to the augmented survival of AML will provide a more reliable substrate for therapeutic strategies in patients with this poor-risk disease.  相似文献   

2.
3.
4.
The effect of 6 wk of either red meat (RM) or fatty fish (FF) intake on plasma lipid concentrations in 28 free-living volunteers (12 males, 16 females) aged 22-45 y was investigated in this clinical crossover trial. Dietary intake was estimated by 7-d dietary records, and fasting blood samples were analyzed for plasma lipid concentrations. Although energy intake did not differ, protein intake was higher (P less than 0.01) in the FF period than in the RM period. There was also a difference (P less than 0.001) in the ratio of dietary polyunsaturated to saturated fatty acids in the RM (0.45) and FF (0.93) periods. Mean plasma total cholesterol, low-density-lipoprotein cholesterol, very-low-density-lipoprotein (VLDL) cholesterol VLDL-triacylglycerol, and plasma triacylglycerol concentrations were lower (P less than 0.001) in the FF than in the RM period. Positive correlations between animal-protein intake and plasma lipoproteins were observed. Atherogenic plasma lipoprotein concentrations were lower when FF was substituted for RM.  相似文献   
5.
6.
7.
Using a unique surgical model (the donor rat model), we showed previously that duodenal replacement of bile-pancreatic juice, obtained fresh from a donor rat, ameliorates ligation-induced acute pancreatitis. We hypothesize that bile-pancreatic juice exclusion from gut exacerbates Akt/nuclear factor-kB (NF-kB) pathway activation and induces chemokine production in ligation-induced acute pancreatitis. We compared rats with bile-pancreatic duct ligation to those with duodenal bile-pancreatic juice replacement fresh from a donor rat beginning immediately before duct ligation. Sham control rats had ducts dissected but not ligated. Rats were killed 1 or 3 hours after operation (n=7/group). Akt activation (immunoblotting, immune-complex kinase assay, and ELISA), inhibitory protein I-kB (I-kB) activation (immunoblotting), and production of chemokines MCP-1 and RANTES (ELISA) were measured in pancreatic homogenates. NF-kB was quantitated in nuclear fractions using electrophoretic mobility shift assay. Duct ligation produced significant increases in pancreatic Akt, IkB, and NF-kB activation and production of MCP-1 and RANTES. Activation of the Akt/NF-kB pathway and increased MCP-1 and RANTES production in response to duct ligation were significantly reduced by bile-pancreatic juice replacement (ANOVA, P<0.05). Bile-pancreatic juice exclusion stimulates Akt/NF-kB pathway activation and increases chemokine production in ligation-induced acute pancreatitis. Presented at the annual meeting of The Society for Surgery of the Alimentary Tract, Chicago, Illinois, May 16, 2005 (poster).  相似文献   
8.
Failure of patient-triggered ventilation in very immature infants may be due to the use of inappropriate triggering systems. Two types of airflow trigger were therefore compared consecutively to an airway pressure (SLE) triggering system. Each comparison was made in 10 infants, ≤28 weeks of gestation. Comparison was made of the delivered volume, trigger performance and blood gases using each system for 1 h. Both comparisons showed that the airflow triggering systems performed better: one (Draeger Babylog 8000) had a higher sensitivity ( p < 0:01) and the other (Bird VIP airflow trigger), in which inflation was terminated by sensing a reduction in inspiratory flow, had a lower degree of asynchrony ( p < 0:01) and a tendency to deliver higher volumes. These results suggest that triggering systems sensing airflow changes may be superior to those sensing airway pressure changes in very immature infants. The use of a mechanism to synchronize the termination of inflation to the end of the patient's inspiration may offer further advantages.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号